NCT01340976 2018-10-03A Phase 1 Study of LY2787106 in Cancer and AnemiaEli Lilly and CompanyPhase 1 Completed33 enrolled 18 charts
NCT00097747 2012-12-21Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy VolunteersAffymaxPhase 1 Completed28 enrolled
NCT00629876 2011-12-01A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.TakedaPhase 1 Terminated2 enrolled